• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.49% Nasdaq Up 0.14%

    Celgene Corporation (CELG)

    -NasdaqGS
    113.66 Down 3.52(3.00%) 10:59AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:117.18
    Open:112.69
    Bid:114.15 x 900
    Ask:114.27 x 500
    1y Target Est:116.68
    Beta:2
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:110.39 - 116.23
    52wk Range:66.85 - 119.84
    Volume:3,005,936
    Avg Vol (3m):5,216,990
    Market Cap:90.78B
    P/E (ttm):59.54
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CELG

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 3.00%90.78B
    JNJUp 0.80%297.80B

    Key Statistics

    Forward P/E (1 yr):23.51
    P/S (ttm):12.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.68
    Quarterly EPS Est (Dec-14) :1.00
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.24

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback